These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 1698994

  • 1. Herpes simplex virus type 1-specific immunity induced by peptides corresponding to an antigenic site of glycoprotein B.
    Mester JC, Highlander SL, Osmand AP, Glorioso JC, Rouse BT.
    J Virol; 1990 Nov; 64(11):5277-83. PubMed ID: 1698994
    [Abstract] [Full Text] [Related]

  • 2. Impact of valency of a glycoprotein B-specific monoclonal antibody on neutralization of herpes simplex virus.
    Krawczyk A, Krauss J, Eis-Hübinger AM, Däumer MP, Schwarzenbacher R, Dittmer U, Schneweis KE, Jäger D, Roggendorf M, Arndt MA.
    J Virol; 2011 Feb; 85(4):1793-803. PubMed ID: 21123390
    [Abstract] [Full Text] [Related]

  • 3. Epitopes of herpes simplex virus type 1 glycoprotein B that bind type-common neutralizing antibodies elicit type-specific antibody-dependent cellular cytotoxicity.
    Sanchez-Pescador L, Paz P, Navarro D, Pereira L, Kohl S.
    J Infect Dis; 1992 Sep; 166(3):623-7. PubMed ID: 1380051
    [Abstract] [Full Text] [Related]

  • 4. Helper T cells induced by an immunopurified herpes simplex virus type I (HSV-I) 115 kilodalton glycoprotein (gB) protect mice against HSV-I infection.
    Chan WL, Lukig ML, Liew FY.
    J Exp Med; 1985 Oct 01; 162(4):1304-18. PubMed ID: 2995536
    [Abstract] [Full Text] [Related]

  • 5. Common epitopes of glycoprotein B map within the major DNA-binding proteins of bovine herpesvirus type 2 (BHV-2) and herpes simplex virus type 1 (HSV-1).
    Hammerschmidt W, Conraths F, Mankertz J, Buhk HJ, Pauli G, Ludwig H.
    Virology; 1988 Aug 01; 165(2):406-18. PubMed ID: 2457278
    [Abstract] [Full Text] [Related]

  • 6. Monoclonal antibodies define a domain on herpes simplex virus glycoprotein B involved in virus penetration.
    Highlander SL, Cai WH, Person S, Levine M, Glorioso JC.
    J Virol; 1988 Jun 01; 62(6):1881-8. PubMed ID: 2452895
    [Abstract] [Full Text] [Related]

  • 7. Use of synthetic peptides to map the antigenic determinants of glycoprotein D of herpes simplex virus.
    Strynadka NC, Redmond MJ, Parker JM, Scraba DG, Hodges RS.
    J Virol; 1988 Sep 01; 62(9):3474-83. PubMed ID: 2457115
    [Abstract] [Full Text] [Related]

  • 8. Analysis of the role of antibody-dependent cellular cytotoxic antibody activity in murine neonatal herpes simplex virus infection with antibodies to synthetic peptides of glycoprotein D and monoclonal antibodies to glycoprotein B.
    Kohl S, Strynadka NC, Hodges RS, Pereira L.
    J Clin Invest; 1990 Jul 01; 86(1):273-8. PubMed ID: 2164044
    [Abstract] [Full Text] [Related]

  • 9. Protection against zosteriform spread of herpes simplex virus by monoclonal antibodies.
    Mester JC, Glorioso JC, Rouse BT.
    J Infect Dis; 1991 Feb 01; 163(2):263-9. PubMed ID: 1846388
    [Abstract] [Full Text] [Related]

  • 10. Induction of neutralizing antibody against varicella-zoster virus (VZV) by VZV gp3 and cross-reactivity between VZV gp3 and herpes simplex viruses gB.
    Kitamura K, Namazue J, Campo-Vera H, Ogino T, Yamanishi K.
    Virology; 1986 Feb 01; 149(1):74-82. PubMed ID: 2418583
    [Abstract] [Full Text] [Related]

  • 11. Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants.
    Bishop GA, Marlin SD, Schwartz SA, Glorioso JC.
    J Immunol; 1984 Oct 01; 133(4):2206-14. PubMed ID: 6206157
    [Abstract] [Full Text] [Related]

  • 12. Induction of protective immunity with antibody to herpes simplex virus type 1 glycoprotein H (gH) and analysis of the immune response to gH expressed in recombinant vaccinia virus.
    Forrester AJ, Sullivan V, Simmons A, Blacklaws BA, Smith GL, Nash AA, Minson AC.
    J Gen Virol; 1991 Feb 01; 72 ( Pt 2)():369-75. PubMed ID: 1704412
    [Abstract] [Full Text] [Related]

  • 13. Monoclonal Antibodies, Derived from Humans Vaccinated with the RV144 HIV Vaccine Containing the HVEM Binding Domain of Herpes Simplex Virus (HSV) Glycoprotein D, Neutralize HSV Infection, Mediate Antibody-Dependent Cellular Cytotoxicity, and Protect Mice from Ocular Challenge with HSV-1.
    Wang K, Tomaras GD, Jegaskanda S, Moody MA, Liao HX, Goodman KN, Berman PW, Rerks-Ngarm S, Pitisuttithum P, Nitayapan S, Kaewkungwal J, Haynes BF, Cohen JI.
    J Virol; 2017 Oct 01; 91(19):. PubMed ID: 28701403
    [Abstract] [Full Text] [Related]

  • 14. Mechanism of neutralization of herpes simplex virus by antibodies directed at the fusion domain of glycoprotein B.
    Cairns TM, Fontana J, Huang ZY, Whitbeck JC, Atanasiu D, Rao S, Shelly SS, Lou H, Ponce de Leon M, Steven AC, Eisenberg RJ, Cohen GH.
    J Virol; 2014 Mar 01; 88(5):2677-89. PubMed ID: 24352457
    [Abstract] [Full Text] [Related]

  • 15. Functional T cell recognition of synthetic peptides corresponding to continuous antibody epitopes of herpes simplex virus type 1 glycoprotein D.
    Wyckoff JH, Osmand AP, Eisenberg RJ, Cohen GH, Rouse BT.
    Immunobiology; 1988 May 01; 177(2):134-48. PubMed ID: 2456985
    [Abstract] [Full Text] [Related]

  • 16. Passive immune protection by herpes simplex virus-specific monoclonal antibodies and monoclonal antibody-resistant mutants altered in pathogenicity.
    Kümel G, Kaerner HC, Levine M, Schröder CH, Glorioso JC.
    J Virol; 1985 Dec 01; 56(3):930-7. PubMed ID: 2415719
    [Abstract] [Full Text] [Related]

  • 17. The Neutralizing Linear Epitope of Human Herpesvirus 6A Glycoprotein B Does Not Affect Virus Infectivity.
    Wakata A, Kanemoto S, Tang H, Kawabata A, Nishimura M, Jasirwan C, Mahmoud NF, Mori Y.
    J Virol; 2018 Mar 01; 92(5):. PubMed ID: 29212944
    [Abstract] [Full Text] [Related]

  • 18. Characterisation of the epitope for a herpes simplex virus glycoprotein B-specific monoclonal antibody with high protective capacity.
    Däumer MP, Schneider B, Giesen DM, Aziz S, Kaiser R, Kupfer B, Schneweis KE, Schneider-Mergener J, Reineke U, Matz B, Eis-Hübinger AM.
    Med Microbiol Immunol; 2011 May 01; 200(2):85-97. PubMed ID: 20931340
    [Abstract] [Full Text] [Related]

  • 19. Monoclonal antibodies to the distinct antigenic sites on glycoproteins C and B and their protective abilities in herpes simplex virus infection.
    Bystrická M, Petríková M, Zatovicová M, Soláriková L, Kostolanský F, Mucha V, Russ G.
    Acta Virol; 1997 Feb 01; 41(1):5-12. PubMed ID: 9199708
    [Abstract] [Full Text] [Related]

  • 20. Dissection of the antibody response against herpes simplex virus glycoproteins in naturally infected humans.
    Cairns TM, Huang ZY, Whitbeck JC, Ponce de Leon M, Lou H, Wald A, Krummenacher C, Eisenberg RJ, Cohen GH.
    J Virol; 2014 Nov 01; 88(21):12612-22. PubMed ID: 25142599
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.